Adherex Reports Recent Developments and Second Quarter June 30, 2013 Financial Results

By admin Final data from Phase III STS Trial Expected in Q3 2013
Company to Focus on Development of Sodium Thiosulfate (STS) for Prevention of Hearing Loss in Pediatric Oncology Patients

Possibility of Commercial Partnership for Eniluracil (EU) will be explored

Research Triangle Park, NC, August 09, 2013 – – Adherex Technologies Inc. (TSX:AHX, OTCQB: ADHXF), today reported […]

Scroll to Top